from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0666/-

LFCtreatmentdescriptionclass of inhibitor

0.039

Amikacinug/mL Amikacintranslation

-0.083

Cap5-10ug/mL Capreomycintranslation

-0.182

Rox10-50 ug/mL Roxithromycintranslation

-0.491

SM2-5 ug/mL Streptomycintranslation

-0.061

Tet5-10 ug/mL Tetracyclinetranslation

0.693

Rif0.2-5ug/mL Rifampicintranscription

1.177

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.179

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.226

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.981

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.166

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.384

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.941

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.037

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.179

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.644

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.455

NaN30.2-2 mM Sodium aziderespiration

-0.474

Nigericin50 uM Nigericinrespiration

-0.021

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.162

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.027

menadione6-10 ug/mL Menadionerespiration

0.471

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.792

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.269

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.547

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.086

NRP_1Non-replicating persistence stage 1dosRassociated

-0.590

Amp0.2mg/mL AmpicillincellWall

0.167

Cephalexin20-100 ug/mL CephalexincellWall

-0.124

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.338

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.362

EMB10-20 ug/mL EthambutolcellWall

-0.232

Eta12-40 ug/mL EthionamidecellWall

-0.090

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.305

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.419

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.677

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.919

BZA0.12 mg/mL BenzamidearomaticAmides

-0.297

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.152

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.001

H2O24 mM hydrogen peroxideDNAdamaging

0.623

Levo10 ug/mL LevofloxacinDNAdamaging

-0.605

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.302

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.849

UVUV-irradiationDNAdamaging

0.519

ARP41-4 ug/mL Antitubercular compound ARP4?

0.617

Antimycin12.5-50 ug/mL Antimycin A?

-0.069

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.690

PA_110-50 ug/mL Antitubercular compound PA-1?

0.392

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.927

PA8240.2-2 ug/mL PA-824?

1.372

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.893

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.878

Verapamil50 uM Verapamil?

-1.364

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.006

methoxatin10-20 ug/mL Methoxatin?